RNAi-induced loss of pat-10 disrupts endocytosis through impairment of the actin cytoskeleton (12, 13, 15) . To assay the role of pat-10 in endocytosis, we used a secretion and endocytosis reporter designed to actively secrete GFP (ssGFP) from muscle cells into the pseudocoelomic fluid, where it is endocytosed by the coelomocyte cells and degraded ( fig. S9A) (16) . Therefore, the ssGFP reports upon effective muscular secretion and endocytosis by coelomocytes. Fitting the hypothesis that pat-10 overexpression improves transport and cellular processing through improved subcellular scaffolding, the pat-10 OE strain had a decrease in overall ssGFP fluorescence (Fig. 3, E and F) . The decrease in ssGFP resulted from improved secretion and uptake, as shown by the absence of fluorescence in the muscle and pseudocoelomic fluid (Fig. 3E ). This decrease was not due to an overall decrease in expression of GFP ( fig. S9B ). Conversely, RNAi of pat-10 increased overall fluorescence through decreased muscle secretion and coelomocytic endocytosis ( Fig. 3 , E and G). To fully block coelomocytic uptake and degradation of ssGFP, RNAi of cup-4, a ligand-gated ion channel required in endocytosis (17) , showed an even higher increase in fluorescence ( Fig. 3G ) and also reduced thermotolerance in the wild type (Fig.  3H) . Collectively, these data indicate pat-10 has an active role in cytoskeletal maintenance, which is critical to cellular transport.
To test for conservation, we disrupted the actin cytoskeleton in human embryonic kidney (HEK) 293T cells using cytochalasin D, which blocks the addition of actin monomers to filaments (18) , or latrunculin A, which binds actin monomers and prevents polymerization (Fig. 4A) (19) . Inhibiting filamentous actin formation with either cytochalasin D or latrunculin A significantly reduced thermotolerance in human cells without causing death at permissive temperatures ( Fig. 4B and  fig. S10 ). Similar to our C. elegans data, these findings reiterate the importance of the actin cytoskeleton during times of cellular stress.
Elevated levels of hsf-1 have been shown to benefit multiple organisms, yet its oncogenic properties are a major therapeutic drawback (20, 21) . Because the inducible chaperone network promotes survival and proliferation of metastasizing cells (22) , the ability to harness protective, nonchaperone components within the HSF-1 signal transduction cascade appears essential for future drug development. Identification of pat-10 as a modifier of thermotolerance and longevity may apply to mammalian systems without the typical oncogenic dangers associated with increased chaperone levels.
The hsf-1(CT) strain was still able to mount a transcriptional response to heat shock, albeit reduced in complexity of hsf-1(FL). The molecular mechanism remains unclear by which hsf-1(CT) regulates transcription without the C-terminal activation domain, but possible explanations include HSF-1 containing multiple activation domains. Alternatively, the hsf-1(CT) modification may alter affinities to DNA-binding sites or different cofactors, which would modify the transcriptional profile.
Our findings underscore the importance of maintaining filamentous actin, as opposed to total levels of actin. We propose a model in which HSF-1 regulates chaperones and actin cytoskeletal genes in parallel to promote thermotolerance and longevity (Fig. 4C ). In the absence of chaperone induction, stabilization of the actin cytoskeleton is sufficient to promote survival under conditions of cellular stress and aging. T cells that mediate autoimmune diseases such as rheumatoid arthritis (RA) are difficult to characterize because they are likely to be deleted or inactivated in the thymus if the self antigens they recognize are ubiquitously expressed. One way to obtain and analyze these autoimmune T cells is to alter T cell receptor (TCR) signaling in developing T cells to change their sensitivity to thymic negative selection, thereby allowing their thymic production. From mice thus engineered to generate T cells mediating autoimmune arthritis, we isolated arthritogenic TCRs and characterized the self antigens they recognized. One of them was the ubiquitously expressed 60S ribosomal protein L23a (RPL23A), with which T cells and autoantibodies from RA patients reacted. This strategy may improve our understanding of the underlying drivers of autoimmunity.
T cells mediate a variety of autoimmune diseases (1, 2), likely through the recognition of self antigens. However, identification of the self antigens targeted by T cells in systemic autoimmune diseases such as rheumatoid arthritis (RA) has been technically difficult (3) (4) (5) . This is because pathogenic T cells expressing high-affinity T cell receptors (TCRs) for ubiquitous self antigens may be largely deleted (i.e., negatively selected) in the thymus and SCIENCE sciencemag.org scarcely detectable in the periphery or, if detected, in an inactivated state (6) . This can be circumvented by altering TCR signaling, which changes the sensitivity of developing T cells to thymic selection and results in new dominant self-reactive TCR specificities that are causative of systemic autoimmune diseases (7) (8) (9) (10) (11) (Fig. 1,  A to C, and fig. S4 , A to C). The two arthritogenic TCRs and a control nonarthritogenic 1-23 TCR used the same Va and Vb gene segments but different Ja and Jb genes and CDR3 sequences (Fig.  1A) . Arthritic joints in retrogenic 7-39 (R7-39) mice showed mononuclear cell infiltration, pannus formation, and cartilage destruction (Fig. 1D) . Some (66.7%) of the R7-39, but not the R6-39, mice also developed chronic dermatitis, which exhibited hyperkeratosis and parakeratosis, histopathological features of human psoriasis (16) (Fig. 1, E (Fig. 1C and fig. S9 ).
Taken together, these results demonstrate that CD4 + T cells with a specific TCR mediate autoimmune arthritis and also dermatitis, and that more than one TCR specificity is individually able to confer T cell arthritogenicity.
We next constructed T cell hybridomas expressing 7-39 or 6-39 TCRs and attempted to determine the self antigens recognized by these TCRs. The 7-39 hybridoma cells produced interleukin-2 (IL-2) when stimulated by cell extracts not only from SKG fibroblast-like synoviocytes (FLSs) but also from P3U1 cells, a BALB/c plasma cellderived cell line ( fig. S10 ). In contrast, syngeneic antigen-presenting cells (APCs) were sufficient to induce IL-2 production by 6-39 hybridoma cells, indicating that the 6-39 TCRs recognized a self antigen constitutively displayed by APCs ( fig.  S4D ). To further characterize the self antigen recognized by 7-39 TCRs, we reconstituted Rag2 −/− mice with a mixture of 7-39 TCR-transfected Rag2 −/− SKG BM cells and TCRb −/− BALB/c BM cells on the assumption that the autoantibodies produced by B cells might specifically react with the self antigen recognized by 7-39 TCRs because T cell help came solely from 7-39 T H cells. The sera from these "B cell-reconstituted" mice specifically reacted with an 18-kD protein from the cell extract of P3U1 cells ( Fig. 2A) . Mass spectrometric analysis identified this protein as RPL23A, a component of the 60S subunit of ribosomes (17, 18) (fig. S11 ). Various organs were found to express RPL23A mRNA at high levels (Fig. 2B) .
The amino acid sequence of RPL23A is 100% conserved between mice and humans (18) . The sera from the B cell-reconstituted R7-39 mice indeed recognized recombinant RPL23A, but not histone H1.2 protein, another candidate protein indicated by the mass spectrometric analysis (Fig. 2C ). In addition, recombinant RPL23A protein specifically stimulated the 7-39 hybridoma cells in a dose-dependent, class II major histocompatibility complex (MHC) I-A d -dependent manner (Fig. 2D and fig. S12 ). Among 20-amino acid RPL23A peptides with consecutive overlapping of 5 amino acid residues, RPL23A 71-90 peptide stimulated 7-39 TCRs most potently (table S3 and fig. S13A ). B cell-reconstituted R7-39 mice and arthritic SKG mice developed antibodies reacting with cyclic citrullinated peptides (CCP), as also observed in RA patients (19) (fig. S14A ), yet there was no significant difference in titer of antibodies to RPL23A whether this was assessed with citrullinated or noncitrullinated RPL23A protein ( fig. S14, B and C) . In addition, the RPL23A 71-90 peptide recognized by 7-39 TCRs contained no arginine residue to be converted to citrulline (table S3) .
Taken together, these results indicate that the ubiquitously expressed protein RPL23A can be a target antigen of both arthritis and dermatitis.
Furthermore, more than one systemic antigen can be targeted for arthritis induction, because the 6-39 TCRs did not react to peptides derived from RPL23A ( fig. S13B ).
Upon transfer, CD4 + T cells, but not sera, from B cell-reconstituted R7-39 mice induced arthritis in Rag2 −/− mice ( fig. S15) . Indeed, CD4 + T cells from arthritic joints or the regional lymph nodes of R7-39 mice produced inflammatory cytokines [including IL-17A, interferon-g (IFN-g), and granulocyte macrophage-colony stimulating factor (GM-CSF)] upon activation with phorbol 12-myristate 13-acetate (PMA) and ionomycin, RPL23A
protein, or RPL23A 71-90 peptide (Fig. 3, A to D,  fig. S16, A to D, and fig. S17 ). In addition, RPL23A stimulated nonarthritic SKG, but not BALB/c, CD4 + T cells to produce IL-17A in vitro (Fig. 3E) . It also augmented the production of IL-17A by CD4 + T cells from SKG mice treated with mannan, which can trigger autoimmune arthritis in SKG mice by promoting T H 17 differentiation of arthritogenic CD4 + T cells (20, 21) . An arthritic joint of SKG mice indeed harbored CD4 + T cells possessing the Vb CDR3 of 7-39 TCRs (table S2) .
We from either ZAP-70-intact BALB/c or ZAP-70-mutant SKG mice failed to suppress arthritis development in Rag2 −/− mice when cotransferred with phenotypically activated or memory 7-39 TCR + CD4 + T cells (figs. S7 and S18), although T reg cells were capable of suppressing naïve arthritogenic T cells effectively (9) .
These results collectively indicate that RPL23A is able to stimulate CD4 + T cells in R7-39 mice via RPL23A-derived peptide-MHC class II complexes, driving them to differentiate into arthritogenic effector T H cells (20) , which are capable of mediating arthritis even in the presence of T reg cells.
Lastly, we examined possible immune responses to RPL23A in RA patients. RPL23A mRNA was found to be ubiquitously expressed in healthy human tissues (Fig. 4A) . In synovial tissues of RA patients and also in the apparently normal synovial tissues of osteoarthritis (OA) patients, RPL23A was detected in the cytoplasm of synovial cells, including CD55 + FLSs (Fig. 4B ). Relative to healthy controls (1.3%, n = 74), a significantly higher proportion of RA patients (16.8%, n = 374) were positive for serum immunoglobulin G-type autoantibodies to RPL23A (Fig.  4C) . Two out of 23 psoriatic arthritis (PsA) patients (8.7%) were positive for the autoantibody, whereas all of the OA patients (n = 11), systemic lupus erythematosus (SLE) patients (n = 30), or SCIENCE sciencemag.org 17 polymyositis/dermatomyositis (PM/DM) patients (n = 10) were negative. In addition, in the synovial fluid of a subset of RA patients, we detected CD4 + T cells producing IFN-g upon stimulation with RPL23A (Fig. 4, D and E) . These findings in humans, together with the key role of anti-RPL23A T cell responses for autoimmune arthritis and psoriasis-like dermatitis in mice, suggest that the responses may play a pathogenic role at least in a subset of patients with RA or PsA.
Our results show that by attenuating TCR signal intensity in developing T cells (hence reducing their sensitivity to thymic negative selection by natural self ligands), T cells reactive with ubiquitously expressed self antigens can be generated as dominant pathogenic clones causing systemic autoimmune disease. Because similar attenuation of TCR signaling at various degrees in conjunction with T reg cell depletion is able to produce a variety of other autoimmune diseases in mice (9, 22) , this strategy of generating pathogenic T cells and characterizing the self antigens they recognize would facilitate our understanding of the mechanisms of other autoimmune diseases of currently unknown etiology. In addition, given that genetic polymorphism in a signaling molecule in T cells is a major determinant of genetic susceptibility to various human autoimmune diseases including RA (23) , such a genetic variation might, at least in part, alter thymic selection, hence forming a TCR repertoire for causing autoimmune disease. Our approach may also be useful in deciphering how T cell autoimmunity to a ubiquitous self antigen triggers localized tissue damage in RA and other human autoimmune diseases, and in devising effective means of systemic or local intervention in the disease process.
